IPWatchdog is pleased to inform readers that this year’s Life Sciences Strategy Summit on IP & Exclusivity will be held on 10-11 October 2023 at Hilton Munich Park Munich.
Following the launch of the Unified Patent Court (UPC) this year, the Life Sciences Strategy Summit on IP & Exclusivity is returning to Munich with an audience of 150+ European life science intellectual property experts for candid discussions and practical updates around the new court system. Find out more here.
With a new patent system in place for the life sciences industry, questions remain around the wider impact of the change and the decision to opt in/opt out. As many companies deliberate over the cost/benefit of the UPC, Global IP Strategy Hub are connecting the senior IP heads from the leading European pharmaceutical and biotech companies with the judicial and regulatory officials directly involved in the new system.
Why attend in October:
- Prepare yourself to navigate this new patent landscape with first-hand judicial insight from our exclusive panel of 6 UPC Judges, including life sciences technical judges and representatives from the Munich and Dusseldorf local divisions
- Update your strategy to overcome the initial challenges for pharma and biotech companies operating within the new system with learnings from our end-user speaker faculty including: Johnson & Johnson, Chr. Hansen & Fresenius Kabi
- 7 Interactive IP Minds Roundtable discussions on: Antibody Case Law, Biosimilar IP Considerations, Arrow Declaration, Clinical Trials and Patent Strategy, AI and Life Science Patents, Trade Secrets vs Patent Protection, FTO: Best Practices
- Join a pre-event day (9 October) focused on SPC & PTE Protection with perspectives from a Pan-European Patent Office Panel, the European Commission, Polpharma, MSD and Fresenius Kabi
For the full list of sessions and speakers at the summit in October, click here.
Join the Discussion
No comments yet.